Coherus BioSciences, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CHRS on Nasdaq
Location
C/O Dennis M. Lanfear, 333 Twin Dolphin Dr, Suite 600, Redwood City, CA

There are no Buy or Sell transactions made by insiders since 12/17/2023

Coherus BioSciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dennis M. Lanfear President & CEO, Director $3M Jul 22, 2024
Vincent R. Anicetti Chief Operating Officer $304K Jul 6, 2021
Vladimir Vexler Chief Scientific Officer $284K Mar 31, 2023
McDavid Stilwell Chief Financial Officer $184K Dec 31, 2023
Mats Wahlstrom Director $167K Jun 3, 2024
Paul Reider Chief Commercial Officer $144K Dec 13, 2024
Bryan J. McMichael Chief Financial Officer $56.1K Aug 7, 2024
James Healy Director Jan 7, 2022
Alan C. Mendelson Director May 21, 2021
Michael Lee Ryan Director Jun 3, 2024
Mark Stolper Director Jun 3, 2024
Rita A. Karachun Director Jun 4, 2024
Kimberly Jo Tzoumakas Director Jun 3, 2024
Charles W. Newton Director Jun 3, 2024
Jill O'Donnell-Tormey Director Jun 3, 2024
Lee Nisley Newcomer Director Jun 3, 2024
Georgia Erbez Director Jun 4, 2024

Recent Insider Transactions by Companies or Individuals for Coherus BioSciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.